Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Sell
46
ARTV Quote, Financials, Valuation and Earnings
Last price:
$4.00
Seasonality move
:
-67.7%
Day range:
$3.89 - $4.14
52-week range:
$1.47 - $7.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
46.79x
P/B ratio:
0.76x
Volume:
40K
Avg. volume:
194.9K
1-year change:
-0.25%
Market cap:
$98.2M
Revenue:
$251K
EPS (TTM):
-$3.25
Earnings Data
Next earnings date for ARTV
--
Most recent earnings per share
-$0.88
Missed by $0.08
(Sep 30/2025)
Consensus Estimate
-$0.80
(Sep 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ARTV Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q1 | -- | -- | -- | -- | -- |
| 12/31/2025 | Q4 | -- | -- | -- | -$0.80 | -- |
| 09/30/2025 | Q3 | -- | -- | -$0.88 | -$0.80 | -$0.08 |
| 08/07/2025 | Q2 | -- | -- | -$0.87 | -$0.77 | -$0.10 |
| 05/08/2025 | Q1 | -- | -- | -$0.83 | -$0.62 | -$0.21 |
| 03/24/2025 | Q4 | $50K | -- | -$0.66 | -$0.58 | -$0.08 |
| 11/12/2024 | Q3 | $75K | -- | -$0.92 | -$0.64 | -$0.29 |
| 08/29/2024 | Q2 | $75K | -- | -$0.62 | -$1.59 | $0.97 |
| 03/31/2024 | Q1 | -- | $251K | -$1.49 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.95 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.69 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.65 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$2.43 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.34 | -- | -- |
Artiva Biotherapeutics, Inc. Earnings Questions
-
How Much did Artiva Biotherapeutics, Inc. Generate in Revenue Last Quarter?
Artiva Biotherapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Artiva Biotherapeutics, Inc. Beat Earnings Last Quarter?
Artiva Biotherapeutics, Inc. announced earnings per share of -$0.88 which represents a miss of analyst forecast a -$0.80 per share.
-
Is Artiva Biotherapeutics, Inc. Profitable?
Artiva Biotherapeutics, Inc. reported -$662K that represents -$0.03 per share over the last quarter.
-
What is the Analyst Consensus for Artiva Biotherapeutics, Inc. EPS Next Year?
Artiva Biotherapeutics, Inc.'s earnings are forecast to decrease from -$2.69 per share to -$3.09 per share next year representing a decrease of -14.82%.
-
When is Artiva Biotherapeutics, Inc.'s Earnings Date?
Currently, Artiva Biotherapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on May 17, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Is Sandisk The Next Big Memory Stock?
Computer memory manufacturer Sandisk (NASDAQ:SNDK) has quietly been one of…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
44
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
77
CPS alert for Feb 14
Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.
Buy
58
TPH alert for Feb 14
Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.
Sell
20
IRON alert for Feb 14
Disc Medicine, Inc. [IRON] is down 21.88% over the past day.
